Back to Business

$FDA approves Hovilpri for refractory HSV in immunocompromised adults$

Business October 9, 2026 at 10:44 PM

FDA approves Hovilpri for refractory HSV in immunocompromised adults

Investing.com

Read the full story at Investing.com

More Stories

Kalshi probes suspicious bets on Trump press secretary pick, WSJ reports

Kalshi probes suspicious bets on Trump press secretary pick, WSJ reports

🇺🇸 Investing.com 55m ago

Astera Labs director Stefan Dyckerhoff sells $4.7m in shares

Astera Labs director Stefan Dyckerhoff sells $4.7m in shares

🇺🇸 Investing.com 1h ago

Cerence EVP Nils Schanz disposes of $419,512 in CRNC shares

Cerence EVP Nils Schanz disposes of $419,512 in CRNC shares

🇺🇸 Investing.com 1h ago

Your world briefing, in your pocket

Curated news from 12 countries and 10 languages. Coming soon on iOS and Android.

Coming soon on App Store Coming soon on Google Play